Skip to content

Non-alcoholic, Fiber-enriched Beer and Its Effect on Blood Glucose Concentration

Non-alcoholic, Fiber-enriched Beer and Its Effect on Blood Glucose Concentration: A Scientific Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07131904
Enrollment
25
Registered
2025-08-20
Start date
2025-08-12
Completion date
2025-10-15
Last updated
2025-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Glucose Concentration, Glycemic Index, Dietary Fiber, Non-alcoholic Beer

Keywords

fiber-enriched beer, functional food, continuous glucose monitoring, postprandial glucose response

Brief summary

This study examines how various non-alcoholic beverages affect blood sugar levels. The beverages are a non-alcoholic, fiber-enriched beer, a conventional non-alcoholic beer, and a sugar solution. Participants drink one of these beverages on different days. Afterwards, a sensor on the upper arm is used to measure the sugar content in the body fluid under the skin over a period of two hours. The aim is to find out how much blood sugar concentration rises after drinking. This will be used to check whether the non-alcoholic, fiber-enriched beer has a more favorable effect on sugar metabolism than conventional beverages. Participation is voluntary, and the data will be treated confidentially.

Interventions

OTHERnon-alcoholic, fiber-enriched beer (FEB)

500 ml FEB consumed once during a test day in a randomized crossover design. Postprandial blood glucose is monitored for 120 minutes using a continuous glucose monitor (FreeStyle Libre 3).

OTHERconventional, non-alcoholic beer

500 ml conventional non-alcoholic beer consumed once during a test day in a randomized crossover design. Postprandial blood glucose is monitored for 120 minutes using a continuous glucose monitor (FreeStyle Libre 3).

Glucose solution containing 12.5 g glucose in 500 ml water, consumed once during a test day in a randomized crossover design. Postprandial blood glucose is monitored for 120 minutes using a continuous glucose monitor (FreeStyle Libre 3).

Sponsors

David Faeh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults aged 18-60 years * Body mass index (BMI) between 18.5 and 29.9 kg/m² * Signed informed consent

Exclusion criteria

* Diagnosed diabetes * Gastrointestinal diseases * Hormonal or other metabolic diseases * Allergies or intolerances to beer ingredients * Professional sports (\>10 hours/week of intense exercise) * Special diets (e.g., low-carb, intermittent fasting) * Sleep disorders or inability to maintain regular sleep (e.g., shift work) * Pregnancy or breastfeeding * Smoking * Inability to speak German or English * Problems with alcohol, drug, or medication abuse * Inability to sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Incremental Area Under the Curve (iAUC) for Postprandial Blood Glucose0-120 minutes after beverage consumption on each test dayIncremental area under the curve for interstitial glucose concentration measured over 120 minutes after beverage consumption. Measurements obtained via continuous glucose monitoring (FreeStyle Libre 3) in a randomized crossover design.

Secondary

MeasureTime frameDescription
Glycemic Index of Fiber-Enriched Beer (FEB)0-120 minutes after beverage consumption on each test dayGlycemic index calculated using the incremental area under the curve for blood glucose after consumption of FEB, compared to glucose solution, according to ISO 26642:2010 methodology.

Contacts

Primary ContactDavid Fäh, Prof.Dr.med
david.faeh@bfh.ch+41 31 848 45 51
Backup ContactNeeser Lorena, Bsc
lorena.neeser@bfh.ch+41 77 423 18 45

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026